Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypersensitivity reaction to paclitaxel: nursing interventions.

J S Myers1

  • 1Research Medical Center, c/o 7 East Oncology, 2316 East Meyer Boulevard, Kansas City, MO 64132, USA. jsmyers@healthmidwest.org

Clinical Journal of Oncology Nursing
|March 23, 2001
PubMed
Summary

Paclitaxel, a cancer drug, can cause hypersensitivity reactions (HSRs) due to its diluent. Premedication and prompt nursing intervention significantly reduce HSR incidence and manage reactions effectively.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ocular hypotensive effect of fixed-combination brinzolamide/brimonidine adjunctive to a prostaglandin analog: a randomized clinical trial.

Eye (London, England)·2016
Same author

Matrix metalloproteinase inhibition in atherosclerosis and stroke.

Current molecular medicine·2013
Same author

Vicarious calibration of the moderate-resolution imaging spectroradiometer airborne simulator thermal-infrared channels.

Applied optics·2008
Same author

Should an iridectomy be routinely performed as a part of trabeculectomy? Two surgeons' clinical experience.

Eye (London, England)·2007
Same author

Comprehensive analysis of a large genomic sequence at the putative B-cell chronic lymphocytic leukaemia (B-CLL) tumour suppresser gene locus.

Mutation research·2001
Same author

Vestiges of life in the oldest Greenland rocks? A review of early Archean geology in the Godthabsfjord region, and reappraisal of field evidence for > 3850 Ma life on Akilia.

Precambrian research·2001

Area of Science:

  • Oncology
  • Pharmacology
  • Clinical Nursing

Background:

  • Paclitaxel is a vital chemotherapy agent for various cancers.
  • Hypersensitivity reactions (HSRs) are a significant concern with paclitaxel administration, often linked to the drug's diluent.
  • Established premedication protocols have shown efficacy in mitigating HSRs.

Purpose of the Study:

  • To highlight the incidence and management of paclitaxel-related hypersensitivity reactions.
  • To emphasize the role of premedication in preventing HSRs.
  • To outline immediate management strategies and the critical role of oncology nurses.

Main Methods:

  • Review of paclitaxel's mechanism of action and associated adverse reactions.
  • Analysis of the impact of premedication regimens (dexamethasone, diphenhydramine, H2-antagonists) on HSR incidence.

Related Experiment Videos

  • Description of the recommended emergency management steps for paclitaxel-induced HSRs.

    • Main Results:

    • Premedication with dexamethasone, diphenhydramine, and H2-histamine antagonists substantially reduces paclitaxel-related HSRs.
    • Immediate management involves stopping infusion, oxygen, fluids, monitoring, and emergency medications.
    • Oncology nurses play a crucial role in timely recognition and intervention.

    Conclusions:

    • Paclitaxel-induced HSRs are manageable with appropriate premedication and prompt nursing care.
    • Standardized emergency protocols are essential for patient safety during paclitaxel infusion.
    • Effective HSR management relies on the vigilance and preparedness of oncology nursing staff.